Skip to main content

Table 4 Infant parasitaemia and anaemia (Hb < 10 g/dl) at 6 and 12 months follow-up

From: Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial

Outcome

ISTi (n/N (%))

PCDi (n/N (%))

aPR (95% CI); p value

Any parasitaemia at 12 months

33/254 (13.1)

57/379 (15.0)

0.92 (0.70–1.21); 0.550

Anaemia at 6 months

66/278 (23.7)

112/392 (28.6)

0.86 (0.66–1.13); 0.280

Anaemia at 12 months

70/254 (28.1)

114/378 (30.2)

0.98 (0.81–1.18); 0.810

  1. Composite of RDT, microscopy or PCR
  2. Adjusted for maternal intervention group; maternal parasitaemia at enrolment or during pregnancy; maternal socioeconomic status (low/medium/high) and infant sex, with random effects at the VHP level to account for clustering
  3. aPR adjusted prevalence ratio, 95% CI 95% confidence interval, ISTii intermittent screening and treatment in infants, PCDii passive case detection in infants